Cell therapy must be regulated as medicine

Experimental Hematology and Oncology

Volumn 5, Issue 1, 2016, Pages

  Li, Zihai ^a   Liu, Delong ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROGRAMMED DEATH 1 RECEPTOR; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; BLOOD TRANSFUSION; CASTRATION RESISTANT PROSTATE CANCER; CELL THERAPY; CLINICAL EFFECTIVENESS; EDITORIAL; HUMAN; IMMUNOTHERAPY; MALPRACTICE; NATURAL KILLER CELL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK BENEFIT ANALYSIS; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 85006226397     PISSN: None     EISSN: 21623619     Source Type: Journal    
DOI: 10.1186/s40164-016-0055-0     Document Type: Editorial

References (10)

1. Starr D. Blood: an epic history of medicine and commerce. New York: Alfred A Knopf; 1998.
2. NICE. Blood transfusion. In: National Institute for Health and Cancer Excellence. Clinical guidelines. London: National Clinical Guideline Centre; 2015.
3. Szczepiorkowski ZM, Dunbar NM. Transfusion guidelines: when to transfuse. Hematol Am Soc Hematol Educ Progr. 2013;2013:638-44.
4. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-74.
5. Li Z, Chen L, Rubinstein MP. Cancer immunotherapy: are we there yet? Exp Hematol Oncol. 2013;2(1):33.
6. June CH, Riddell SR, Schumacher TN. Adoptive cellular therapy: a race to the finish line. Sci Transl Med. 2015;7(280):2807.
7. Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. New Engl J Med. 2010;363(5):411-22.
8. Sipp D. The unregulated commercialization of stem cell treatments: a global perspective. Front Med. 2011;5(4):348-55.
9. de Freitas DR. The regulatory pathway for advanced cell therapy and gene therapy products in brazil: a road to be built. Adv Exp Med Biol. 2015;871:213-9.
10. Turner L, Knoepfler P. Selling stem cells in the USA: assessing the direct-to-consumer industry. Cell Stem Cell. 2016;19(2):154-7.